01/10/2021
The AustralaSian COVID-19 Trial, is a multi-centre randomised adaptive platform clinical trial to assess clinical, virological, and immunological outcomes in patients with SARS-CoV-2 infection (COVID-19). The New Zealand arm of the study is led by CM Health clinical microbiologist and infectious disease consultant, Dr Susan Morpeth.
Read more
31/03/2021
CM Health ophthalmologist and new researcher to MMCT, Dr Rasha Al Taie, has recently been successful in receiving funding from the Potters Masonic Trust, with help from our grants team, for a study investigating the early detection of keratoconus through artificial intelligence.
Read more
03/12/2020
Dr Jon Mathy is a researcher and plastic surgeon, who has been with Middlemore Hospital since 2010. He has a huge desire to improve patient care, particularly surrounding wound healing and management of surgical site infections. Dr Mathy and his co-collaborators have recently been awarded a research activation grant from the New Zealand Health Research Council (HRC) as an initial investigation into the use of anti-staphylococcal bundles in reducing post-IBBR SSIs.
Read more
10/11/2020
We are pleased to announce the formal opening of our infusion suite at Middlemore Clinical Trials with the advent of a karakia (blessing) and the bestowing of a Te Reo Māori name on the suite.
Read more
17/09/2020
Middlemore Clinical Trials is pleased to present our Annual Report 2020.
Read more
10/06/2020
Counties Manukau Health doctors are leading a trial to find possible treatments for bronchiectasis.
Read more
15/11/2019
Yesterday, Ian Town (Chief Science Advisor, Ministry of Health) visited Middlemore Clinical Trials and presented at Middlemore Hospital’s Grand Round on the New Zealand Health Research Strategy 2017 – 2027.
Read more
27/09/2019
Renal Department Middlemore Hospital, Auckland, New Zealand Principal Investigator: Dr Chris Hood Site: Middlemore Clinical Trials (MMCT)
Read more
27/09/2019
The Cath Lab; Coronary Care Unit (CCU) and Middlemore Clinical Trials (MMCT) have been involved in a novel stent trial this year, recruiting 10 trial participants to-date (target of 7 participants) making Middlemore Hospital the highest recruiting site for the trial. Dr Douglas Scott (Primary Investigator) and Kavita Gounder (Primary Research Nurse – MMCT) have therefore been invited by the Trial Sponsor (Elixir Medical Corporation) to attend the TCT2019 Conference.
Read more
23/09/2019
As of September 2019 MMCT has a new current trials feature available on the MMCT website. This will allow GP's and specialists to direct refer a patient to a trial with just a few simple clicks, after which MMCT staff will contact the patient for trial vetting and acceptance.
Read moreMiddlemore Clinical Trials is a fully integrated research unit based at Middlemore Hospital in the heart of South Auckland, New Zealand.
We perform biopharma and medical device clinical trials in partnership with all hospital departments focusing on the diseases and Long term health conditions that affect our diverse community.
